Ovation Science Inc
Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States. The company's patented skin delivery technology Invisicare, a patented polymer-based technology for topical and transdermal skin care products under the Ovation brand name. It also offers cannabis health and wellness solutions under the Invibe MD name; anti-aging products and… Read more
Ovation Science Inc (OVATF) - Total Assets
Latest total assets as of September 2025: $28.80K USD
Based on the latest financial reports, Ovation Science Inc (OVATF) holds total assets worth $28.80K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ovation Science Inc - Total Assets Trend (2017–2024)
This chart illustrates how Ovation Science Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ovation Science Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Ovation Science Inc's total assets of $28.80K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.2% |
| Accounts Receivable | $31.75K | 49.7% |
| Inventory | $28.84K | 45.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Ovation Science Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ovation Science Inc's current assets represent 100.0% of total assets in 2024, an increase from 32.5% in 2017.
- Cash Position: Cash and equivalents constituted 5.2% of total assets in 2024, down from 30.9% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 67.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 49.7% of total assets.
Ovation Science Inc Competitors by Total Assets
Key competitors of Ovation Science Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Ovation Science Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Ovation Science Inc generates 1.77x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Ovation Science Inc is currently not profitable relative to its asset base.
Ovation Science Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.02 | 0.07 | 17.36 |
| Quick Ratio | 0.01 | 0.04 | 11.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.42 Million | $ -948.51K | $ 2.35 Million |
Ovation Science Inc - Advanced Valuation Insights
This section examines the relationship between Ovation Science Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.35 |
| Latest Market Cap to Assets Ratio | 15.51 |
| Asset Growth Rate (YoY) | -16.9% |
| Total Assets | $63.90K |
| Market Capitalization | $991.02K USD |
Valuation Analysis
Premium Asset Valuation: The market values Ovation Science Inc's assets at a significant premium ( 15.51x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Ovation Science Inc's assets decreased by 16.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Ovation Science Inc (2017–2024)
The table below shows the annual total assets of Ovation Science Inc from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $63.90K | -16.89% |
| 2023-12-31 | $76.89K | -26.69% |
| 2022-12-31 | $104.89K | -86.38% |
| 2021-12-31 | $769.90K | -76.32% |
| 2020-12-31 | $3.25 Million | +76.74% |
| 2019-12-31 | $1.84 Million | -32.49% |
| 2018-12-31 | $2.73 Million | +203.04% |
| 2017-12-31 | $899.32K | -- |